Login / Signup

Recombinant CCL17-dependent CCR4 activation alleviates neuroinflammation and neuronal apoptosis through the PI3K/AKT/Foxo1 signaling pathway after ICH in mice.

Shuixiang DengPeng JinPrativa SherchanShengpeng LiuYuhui CuiLei HuangJohn H ZhangYe GongJi-Ping Tang
Published in: Journal of neuroinflammation (2021)
rCCL17-dependent CCR4 activation ameliorated neurological deficits, reduced brain edema, and ameliorated neuroinflammation and neuronal apoptosis, at least in part, through the PI3K/AKT/Foxo1 signaling pathway after ICH. Thus, activation of CCR4 may provide a promising therapeutic approach for the early management of ICH.
Keyphrases